Skip to content

Application Research on Information-Based Risk Prediction Scheme for Carbapenem-Resistant Enterobacteriaceae Infections

Application Research on Information-Based Risk Prediction Scheme for Carbapenem-Resistant Enterobacteriaceae Infections

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113287
Enrollment
Unknown
Registered
2025-11-26
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multidrug-resistant bacteria infection

Interventions

Ward 1 (Control Group):A passive screening method is adopted. Etiological tests are prescribed based on the patients clinical symptoms, and corresponding prevention and control interventions are given
Ward 1 (Active screening and isolation group):Intervention Protocol 1 (Evidence-based research oriented): Based on the "Standards for Prevention and Control of Carbapenem-Resistant Enterobacteriaceae"
Ward 2 (Control Group):A passive screening method is adopted. Etiological tests are prescribed based on the patients clinical symptoms, and corresponding prevention and control interventions are given
Ward 2 (Risk Prediction Isolation Group):Intervention Protocol 2 (Information tool oriented): The "Multidrug-Resistant Organism Hospital Infection Risk Calculator" was used to automatically identify C

Sponsors

The Fifth Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) All patients admitted to the general ICU department; (2) Patients aged >= 18 years old;

Exclusion criteria

Exclusion criteria: (1) Patients with definite MDRO infection upon admission to the ICU; (2) Patients who are discharged automatically or die within 24 hours of treatment; (3) Patients during the outbreak period of nosocomial infections are not included in the research subjects or related categories;

Design outcomes

Primary

MeasureTime frame
CRE infection rate;

Secondary

MeasureTime frame
mortality rate;CRE detection rate;CRE active screening rate;CRE isolation rate;

Countries

China

Contacts

Public ContactTian Ping

the Fifth Affiliated Hospital of Xinjiang Medical University

1140446516@qq.com+86 189 9917 8383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026